Collectively, the data presented here demonstrate that these four proteins, HMMR, NXPH4, PITX and THBS4, are novel secretory biomarkers for diagnosing HCC patients at an early stage of HCC development. This evidence concerns the gene HMMR and hepatocellular carcinoma.